Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Body unavailable. Use the original source.
Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths